238 related articles for article (PubMed ID: 22065579)
1. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
Gibbs PE; Miralem T; Lerner-Marmarosh N; Tudor C; Maines MD
J Biol Chem; 2012 Jan; 287(2):1066-79. PubMed ID: 22065579
[TBL] [Abstract][Full Text] [Related]
2. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
[TBL] [Abstract][Full Text] [Related]
3. The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Tudor C; Hagen FK; Maines MD
J Biol Chem; 2012 Jul; 287(29):24698-712. PubMed ID: 22584576
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
5. Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
Maines MD; Miralem T; Lerner-Marmarosh N; Shen J; Gibbs PE
J Biol Chem; 2007 Mar; 282(11):8110-22. PubMed ID: 17227757
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.
Gibbs PE; Miralem T; Maines MD
FASEB J; 2010 Sep; 24(9):3239-54. PubMed ID: 20410444
[TBL] [Abstract][Full Text] [Related]
7. Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.
Miralem T; Gibbs PE; Revert F; Saus J; Maines MD
J Biol Chem; 2010 Apr; 285(17):12551-8. PubMed ID: 20177069
[TBL] [Abstract][Full Text] [Related]
8. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase.
Gibbs PE; Maines MD
Int J Cancer; 2007 Dec; 121(11):2567-74. PubMed ID: 17683071
[TBL] [Abstract][Full Text] [Related]
9. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.
Rosati R; Patki M; Chari V; Dakshnamurthy S; McFall T; Saxton J; Kidder BL; Shaw PE; Ratnam M
J Biol Chem; 2016 Dec; 291(50):25983-25998. PubMed ID: 27793987
[TBL] [Abstract][Full Text] [Related]
10. Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
FASEB J; 2007 Dec; 21(14):3949-62. PubMed ID: 17639074
[TBL] [Abstract][Full Text] [Related]
11. Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C.
Gibbs PE; Tudor C; Maines MD
Front Pharmacol; 2012; 3():31. PubMed ID: 22419908
[TBL] [Abstract][Full Text] [Related]
12. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
Zhang J; Zhou B; Zheng CF; Zhang ZY
J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of protein kinase Cδ inhibits inducible nitric oxide synthase expression through IRF1.
Leppänen T; Korhonen R; Laavola M; Nieminen R; Tuominen RK; Moilanen E
PLoS One; 2013; 8(1):e52741. PubMed ID: 23326354
[TBL] [Abstract][Full Text] [Related]
14. Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor.
Gibbs PE; Lerner-Marmarosh N; Poulin A; Farah E; Maines MD
FASEB J; 2014 Jun; 28(6):2478-91. PubMed ID: 24568842
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin.
Kapitulnik J; Maines MD
Trends Pharmacol Sci; 2009 Mar; 30(3):129-37. PubMed ID: 19217170
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cdelta and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-kappaB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro.
Bhatt KH; Pandey RK; Dahiya Y; Sodhi A
Mol Immunol; 2010 Jan; 47(4):861-70. PubMed ID: 19931912
[TBL] [Abstract][Full Text] [Related]
17. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.
Tudor C; Lerner-Marmarosh N; Engelborghs Y; Gibbs PE; Maines MD
Biochem J; 2008 Aug; 413(3):405-16. PubMed ID: 18412543
[TBL] [Abstract][Full Text] [Related]
18. n-Propyl gallate suppresses lipopolysaccharide-induced inducible nitric oxide synthase activation through protein kinase Cδ-mediated up-regulation of heme oxygenase-1 in RAW264.7 macrophages.
Jeon W; Park SJ; Kim BC
Eur J Pharmacol; 2017 Apr; 801():86-94. PubMed ID: 28286125
[TBL] [Abstract][Full Text] [Related]
19. Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast).
Platten M; Eitel K; Wischhusen J; Dichgans J; Weller M
Biochem Pharmacol; 2003 Oct; 66(7):1263-70. PubMed ID: 14505805
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
Burkhard KA; Chen F; Shapiro P
J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
